[HTML][HTML] Molecular analysis of a public cross-neutralizing antibody response to SARS-CoV-2
As severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concerns
(VOCs) continue to emerge, cross-neutralizing antibody responses become key toward next …
(VOCs) continue to emerge, cross-neutralizing antibody responses become key toward next …
[HTML][HTML] Light chain of a public SARS-CoV-2 class-3 antibody modulates neutralization against Omicron
The pairing of antibody genes IGHV2-5/IGLV2-14 is established as a public immune
response that potently cross-neutralizes SARS-CoV-2 variants, including Omicron, by …
response that potently cross-neutralizes SARS-CoV-2 variants, including Omicron, by …
[HTML][HTML] SARS-CoV-2 specific antibody and neutralization assays reveal the wide range of the humoral immune response to virus
M Dogan, L Kozhaya, L Placek, C Gunter… - Communications …, 2021 - nature.com
Abstract Development of antibody protection during SARS-CoV-2 infection is a pressing
question for public health and for vaccine development. We developed highly sensitive …
question for public health and for vaccine development. We developed highly sensitive …
Dissecting the intricacies of human antibody responses to SARS-CoV-1 and SARS-CoV-2 infection
R Wang, Y Han, R Zhang, J Zhu, X Nan, Y Liu, Z Yang… - Immunity, 2023 - cell.com
The 2003 severe acute respiratory syndrome coronavirus (SARS-CoV-1) causes more
severe disease than SARS-CoV-2, which is responsible for COVID-19. However, our …
severe disease than SARS-CoV-2, which is responsible for COVID-19. However, our …
SARS-CoV-2 Beta variant infection elicits potent lineage-specific and cross-reactive antibodies
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Beta variant of concern
(VOC) resists neutralization by major classes of antibodies from COVID-19 patients and …
(VOC) resists neutralization by major classes of antibodies from COVID-19 patients and …
[HTML][HTML] Isolation and characterization of cross-neutralizing coronavirus antibodies from COVID-19+ subjects
MF Jennewein, AJ MacCamy, NR Akins, J Feng… - Cell reports, 2021 - cell.com
SARS-CoV-2 is one of three coronaviruses that have crossed the animal-to-human barrier
and caused widespread disease in the past two decades. The development of a universal …
and caused widespread disease in the past two decades. The development of a universal …
[HTML][HTML] Cross-reactivity of SARS-CoV structural protein antibodies against SARS-CoV-2
In the ongoing coronavirus disease 2019 (COVID-19) pandemic, there remain unanswered
questions regarding the nature and significance of the humoral immune response toward …
questions regarding the nature and significance of the humoral immune response toward …
[HTML][HTML] Cross-reactive antibody response between SARS-CoV-2 and SARS-CoV infections
Summary The World Health Organization has declared the ongoing outbreak of COVID-19,
which is caused by a novel coronavirus SARS-CoV-2, a pandemic. There is currently a lack …
which is caused by a novel coronavirus SARS-CoV-2, a pandemic. There is currently a lack …
[HTML][HTML] Characterization of neutralizing antibodies from a SARS-CoV-2 infected individual
B cells specific for the SARS-CoV-2 S envelope glycoprotein spike were isolated from a
COVID-19-infected subject using a stabilized spike-derived ectodomain (S2P) twenty-one …
COVID-19-infected subject using a stabilized spike-derived ectodomain (S2P) twenty-one …
[HTML][HTML] Molecular features of IGHV3-53-encoded antibodies elicited by SARS-CoV-2
An elegant paper by Yuan et al., recently published in Science, provides novel insights into
the molecular features of neutralizing antibody responses to the severe acute respiratory …
the molecular features of neutralizing antibody responses to the severe acute respiratory …